Drugs.com
JULY 27, 2024
SATURDAY, July 27, 2024 -- As scorching temperatures continue to plague the United States this summer, millions of Americans are at risk for dehydration and heat-linked illness.But what about their medications? Can rising temperatures render those.
Drug Patent Watch
JULY 27, 2024
This chart shows the pharmaceutical companies with the most patents in South Africa. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Perficient: Drug Development
JULY 27, 2024
Welcome to the next installment in our UX in Universal Design series! This edition focuses on the key principles of usability for keyboard access specifically tailored for individuals with physical disabilities within health systems. Ensuring that healthcare digital interfaces are accessible via keyboard navigation is crucial for providing equitable care and improving patient outcomes.
Drug Patent Watch
JULY 27, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Perficient: Drug Development
JULY 27, 2024
Welcome to another installment in our UX in Universal Design series! This edition focuses on the key principles of usability for voice control and speech recognition specifically tailored for individuals with physical disabilities within health systems. Voice control and speech recognition technologies are essential tools for enhancing accessibility and improving patient experiences.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drug Patent Watch
JULY 27, 2024
Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncol Eli Lilly and is included in two NDAs. It is available from one supplier.
Drug Patent Watch
JULY 27, 2024
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […] Source
Expert insights. Personalized for you.
263 
Let's personalize your content